Conversely, BAG3 silencing in HS-5 cells markedly reversed the enhancement of BTK phosphorylation and BCL-2 protein levels in B-CLL cells (Fig. 2B), which is also consistent with the apoptotic trends in the same experimental settings. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.